263 related articles for article (PubMed ID: 26797402)
1. Comparing Outcomes with Bone Marrow or Peripheral Blood Stem Cells as Graft Source for Matched Sibling Transplants in Severe Aplastic Anemia across Different Economic Regions.
Kumar R; Kimura F; Ahn KW; Hu ZH; Kuwatsuka Y; Klein JP; Pasquini M; Miyamura K; Kato K; Yoshimi A; Inamoto Y; Ichinohe T; Wood WA; Wirk B; Seftel M; Rowlings P; Marks DI; Schultz KR; Gupta V; Dedeken L; George B; Cahn JY; Szer J; Lee JW; Ho AY; Fasth A; Hahn T; Khera N; Dalal J; Bonfim C; Aljurf M; Atsuta Y; Saber W
Biol Blood Marrow Transplant; 2016 May; 22(5):932-40. PubMed ID: 26797402
[TBL] [Abstract][Full Text] [Related]
2. HLA-matched sibling transplantation with BM and CD34(+)-purified PBSCs in adult patients with high-risk severe aplastic anemia to overcome graft rejection without an increase in GVHD.
Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Min WS; Park CW; Kim CC; Lee JW
Bone Marrow Transplant; 2010 Oct; 45(10):1497-501. PubMed ID: 20062099
[TBL] [Abstract][Full Text] [Related]
3. [Outcome of allogeneic hematopoietic stem cell transplantation from HLA-matched sibling donor for 41 cases of severe aplastic anemia].
Chen X; Wei JL; Huang Y; He Y; Yang DL; Jiang EL; Ma QL; Zhou LK; Lin XT; Shen YY; Feng SZ; Han MZ
Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):610-4. PubMed ID: 23134851
[TBL] [Abstract][Full Text] [Related]
4. Comparison of outcomes after transplantation of G-CSF-stimulated bone marrow grafts versus bone marrow or peripheral blood grafts from HLA-matched sibling donors for patients with severe aplastic anemia.
Chu R; Brazauskas R; Kan F; Bashey A; Bredeson C; Camitta B; Chiang KY; Frangoul H; Gale RP; Gee A; George B; Goldman FD; Gross TG; Gupta V; Hale GA; Isola L; Ispizua AU; Lazarus H; Marsh J; Russell J; Sabloff M; Waller EK; Eapen M
Biol Blood Marrow Transplant; 2011 Jul; 17(7):1018-24. PubMed ID: 21034842
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups.
Bacigalupo A; Socié G; Schrezenmeier H; Tichelli A; Locasciulli A; Fuehrer M; Risitano AM; Dufour C; Passweg JR; Oneto R; Aljurf M; Flynn C; Mialou V; Hamladji RM; Marsh JC;
Haematologica; 2012 Aug; 97(8):1142-8. PubMed ID: 22315497
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic stem cell transplantation for high-risk adult patients with severe aplastic anemia; reduction of graft failure by enhancing stem cell dose.
Min CK; Kim DW; Lee JW; Han CW; Min WS; Kim CC
Haematologica; 2001 Mar; 86(3):303-10. PubMed ID: 11255278
[TBL] [Abstract][Full Text] [Related]
7. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D
Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704
[TBL] [Abstract][Full Text] [Related]
8. The Latin American experience of allografting patients with severe aplastic anaemia: real-world data on the impact of stem cell source and ATG administration in HLA-identical sibling transplants.
Gómez-Almaguer D; Vázquez-Mellado A; Navarro-Cabrera JR; Abello-Polo V; Milovic V; García J; Basquiera AL; Saba S; Balladares G; Vela-Ojeda J; Gómez S; Karduss-Aurueta A; Bustinza-Álvarez A; Requejo A; Feldman L; Jaime-Pérez JC; Yantorno S; Kusminsky G; Gutiérrez-Aguirre CH; Arbelbide J; Martinez-Rolon J; Jarchum G; Jaimovich G; Riera L; Pedraza-Mesa E; Villamizar-Gómez L; Herrera-Rojas MÁ; Gamboa-Alonso MM; Foncuberta C; Rodríguez-González G; García Ruiz-Esparza MA; Hernández-Maldonado E; Paz-Infanzón M; González-López E; Ruiz-Argüelles GJ
Bone Marrow Transplant; 2017 Jan; 52(1):41-46. PubMed ID: 27548465
[TBL] [Abstract][Full Text] [Related]
9. Second allogeneic stem cell transplant for aplastic anaemia: a retrospective study by the Severe Aplastic Anaemia Working Party of the European Society for Blood and Marrow Transplantation.
Cesaro S; Peffault de Latour R; Tridello G; Pillon M; Carlson K; Fagioli F; Jouet JP; Koh MB; Panizzolo IS; Kyrcz-Krzemien S; Maertens J; Rambaldi A; Strahm B; Blaise D; Maschan A; Marsh J; Dufour C;
Br J Haematol; 2015 Nov; 171(4):606-14. PubMed ID: 26304743
[TBL] [Abstract][Full Text] [Related]
10. Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMT.
Dufour C; Veys P; Carraro E; Bhatnagar N; Pillon M; Wynn R; Gibson B; Vora AJ; Steward CG; Ewins AM; Hough RE; de la Fuente J; Velangi M; Amrolia PJ; Skinner R; Bacigalupo A; Risitano AM; Socie G; Peffault de Latour R; Passweg J; Rovo A; Tichelli A; Schrezenmeier H; Hochsmann B; Bader P; van Biezen A; Aljurf MD; Kulasekararaj A; Marsh JC; Samarasinghe S
Br J Haematol; 2015 Nov; 171(4):585-94. PubMed ID: 26223288
[TBL] [Abstract][Full Text] [Related]
11. T Cell-Depleted Peripheral Blood versus Unmanipulated Bone Marrow in Matched Sibling Transplantation for Aplastic Anemia.
Chorão P; Montoro J; Balaguer-Roselló A; Guerreiro M; Villalba M; Facal A; Solves P; Gómez-Segui I; Pasquini MC; Granados P; Bataller A; Louro A; de la Rubia J; Sanz MA; Sanz J
Transplant Cell Ther; 2023 May; 29(5):322.e1-322.e5. PubMed ID: 36682469
[TBL] [Abstract][Full Text] [Related]
12. Retrospective study of alemtuzumab vs ATG-based conditioning without irradiation for unrelated and matched sibling donor transplants in acquired severe aplastic anemia: a study from the British Society for Blood and Marrow Transplantation.
Marsh JC; Pearce RM; Koh MB; Lim Z; Pagliuca A; Mufti GJ; Perry J; Snowden JA; Vora AJ; Wynn RT; Russell N; Gibson B; Gilleece M; Milligan D; Veys P; Samarasinghe S; McMullin M; Kirkland K; Cook G;
Bone Marrow Transplant; 2014 Jan; 49(1):42-8. PubMed ID: 23912664
[TBL] [Abstract][Full Text] [Related]
13. Successful allogeneic hematopoietic stem cell transplantation using triple agent immunosuppression in severe aplastic anemia patients.
Kim HJ; Park CY; Park YH; Kim YJ; Kim DW; Min WS; Kim CC
Bone Marrow Transplant; 2003 Jan; 31(2):79-86. PubMed ID: 12621487
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic hematopoietic stem cell transplantation in children with aplastic anemia.
Xue HM; Xu HG; Huang K; Guo HX; Li Y; Zhou DH; Huang SL; Fang JP; Chen C
Genet Mol Res; 2015 May; 14(2):5234-45. PubMed ID: 26125718
[TBL] [Abstract][Full Text] [Related]
15. Effect of Stem Cell Source and Dose on Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Idiopathic Aplastic Anemia: Data from the Korean Aplastic Anemia Trials.
Kim H; Lee KH; Sohn SK; Kim I; Kim SH; Park Y; Choi JH; Kwak JY; Kim MK; Bae SH; Shin HJ; Won JH; Lee WS; Choi Y;
Acta Haematol; 2020; 143(3):232-243. PubMed ID: 31390612
[TBL] [Abstract][Full Text] [Related]
16. Hematopoietic stem cell transplantation in children and young adults with secondary myelodysplastic syndrome and acute myelogenous leukemia after aplastic anemia.
Yoshimi A; Strahm B; Baumann I; Furlan I; Schwarz S; Teigler-Schlegel A; Walther JU; Schlegelberger B; Göhring G; Nöllke P; Führer M; Niemeyer CM
Biol Blood Marrow Transplant; 2014 Mar; 20(3):425-9. PubMed ID: 24316460
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic stem cell transplantation for children with acquired severe aplastic anaemia: a retrospective study by the Viva-Asia Blood and Marrow Transplantation Group.
Chen J; Lee V; Luo CJ; Chiang AK; Hongeng S; Tan PL; Tan AM; Sanpakit K; Li CF; Lee AC; Chua HC; Okamoto Y
Br J Haematol; 2013 Aug; 162(3):383-91. PubMed ID: 23735201
[TBL] [Abstract][Full Text] [Related]
18. Peripheral blood as a preferable source of stem cells for salvage transplantation in patients with graft failure after cord blood transplantation: a retrospective analysis of the registry data of the Japanese Society for Hematopoietic Cell Transplantation.
Fuji S; Nakamura F; Hatanaka K; Taniguchi S; Sato M; Mori S; Sakamaki H; Yabe H; Miyamoto T; Kanamori H; Ueda Y; Kawa K; Kato K; Suzuki R; Atsuta Y; Tamaki T; Kanda Y
Biol Blood Marrow Transplant; 2012 Sep; 18(9):1407-14. PubMed ID: 22430086
[TBL] [Abstract][Full Text] [Related]
19. Pilot trial of risk-adapted cyclophosphamide intensity based conditioning and HLA matched sibling and unrelated cord blood stem cell transplantation in newly diagnosed pediatric and adolescent recipients with acquired severe aplastic anemia.
McGuinn C; Geyer MB; Jin Z; Garvin JH; Satwani P; Bradley MB; Bhatia M; George D; Duffy D; Morris E; van de Ven C; Schwartz J; Baxter-Lowe LA; Cairo MS
Pediatr Blood Cancer; 2014 Jul; 61(7):1289-94. PubMed ID: 24623601
[TBL] [Abstract][Full Text] [Related]
20. Matched sibling versus matched unrelated allogeneic hematopoietic stem cell transplantation in children with severe acquired aplastic anemia: experience of the polish pediatric group for hematopoietic stem cell transplantation.
Szpecht D; Gorczyńska E; Kałwak K; Owoc-Lempach J; Choma M; Styczyński J; Goździk J; Dłużniewska A; Wysocki M; Kowalczyk JR; Chybicka A; Pieczonka A; Wachowiak J
Arch Immunol Ther Exp (Warsz); 2012 Jun; 60(3):225-33. PubMed ID: 22527354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]